Switch to:
More From Other Websites
Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After... Jul 22 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 27 2014
Cara Therapeutics appoints Medve Chief Medical Officer Jun 24 2014
Data Published in the New England Journal of Medicine Demonstrate that Naloxegol Improved... Jun 19 2014
The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene,... Jun 19 2014
NEKTAR THERAPEUTICS Files SEC form 8-K, Other Events Jun 18 2014
Regado Biosciences: The Revolyxis Revolution Has Begun Jun 17 2014
Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77% Jun 16 2014
A Nektar Victory Jun 14 2014
Relief for Nektar after AADPAC Voting Jun 13 2014
[$$] Two Undervalued Biopharmas to Buy Now Jun 13 2014
3 Stocks Driving The Drugs Industry Higher Jun 13 2014
[$$] Nektar Shares Rise on FDA Panel Recommendation Jun 12 2014
US FDA ADVISORY COMMITTEE RECOMMENDS NO CARDIOVASCULAR OUTCOMES TRIAL FOR PERIPHERALLY-ACTING... Jun 12 2014
Panel does not back CV safety trials for OIC drugs, Reuters says Jun 12 2014
FDA panel advises against large opioid-constipation drug trials Jun 12 2014


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide